var data={"title":"Computed tomographic and positron emission tomographic scanning of pulmonary nodules","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Computed tomographic and positron emission tomographic scanning of pulmonary nodules</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/contributors\" class=\"contributor contributor_credentials\">Paul Stark, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/contributors\" class=\"contributor contributor_credentials\">Nestor L Muller, MD, PhD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/contributors\" class=\"contributor contributor_credentials\">Geraldine Finlay, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/contributors\" class=\"contributor contributor_credentials\">Susanna I Lee, MD, PhD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Nov 16, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Computed tomography (CT) is an important tool in the evaluation of solitary and multiple pulmonary nodules. It determines the morphology and attenuation characteristics of nodules, defines additional nodules that may not be visible on conventional radiography, and detects additional intrathoracic abnormalities, such as enlarged mediastinal lymph nodes. CT provides clues to the nature of the nodule(s), as well as global thoracic assessment that may help guide patient management. (See <a href=\"topic.htm?path=high-resolution-computed-tomography-of-the-lungs\" class=\"medical medical_review\">&quot;High resolution computed tomography of the lungs&quot;</a>.)</p><p>Positron emission tomography (PET) is a nuclear imaging modality that provides insight into the metabolic activity of a pulmonary lesion and, by inference, yields information about the probability of malignancy. (See <a href=\"topic.htm?path=thoracic-positron-emission-tomography\" class=\"medical medical_review\">&quot;Thoracic positron emission tomography&quot;</a>.)</p><p>The use of CT and PET in the evaluation of solitary or multiple pulmonary nodules will be presented here. General issues related to the differential diagnosis and evaluation of the solitary pulmonary nodule are discussed separately. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-the-incidental-pulmonary-nodule\" class=\"medical medical_review\">&quot;Diagnostic evaluation of the incidental pulmonary nodule&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">COMPUTED TOMOGRAPHY (CT)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>CT is the imaging modality most often used to evaluate pulmonary nodules. In this section, we review technical aspects of CT and the use of CT in the evaluation of pulmonary nodules.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Technical aspects</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Helical CT (ie, spiral CT) has several technical advantages in the evaluation of pulmonary nodules, compared to conventional, axial, step and shoot CT:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Helical CT performed with sustained respiration (ie, breath hold), eliminates the misalignment associated with respiratory motion and assures contiguity from section to section. As a result, helical CT detects up to 40 percent more nodules than conventional CT and consequently has replaced the latter technique [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/1-3\" class=\"abstract_t\">1-3</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Helical CT nearly eliminates respiratory motion artifacts that are seen in up to 10 percent of conventional CT scans.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Reconstruction of axial sections (0.5 mm to 2 mm in thickness from the helical data set with overlapping intervals, at least half the section thickness, according to Nyquist's sampling theorem that requires a system resolution at least double the object resolution in order to avoid partial volume effects or aliasing) facilitates the densitometric analysis of nodules and improves the detection of fat or calcium in nodules. The accuracy of CT attenuation is thus enhanced if the reconstructed section thickness is less than one-half the diameter of the nodule [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/1\" class=\"abstract_t\">1</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Complex pulmonary masses, like arteriovenous malformations or rounded atelectasis, can be well characterized by three-dimensional volume rendering of the helical data set. Nonenhanced three-dimensional reformatting of arteriovenous malformations facilitates analysis of the angioarchitecture. Contrast-enhanced CT studies are important as well, since they allow exclusion of thrombi in the arteriovenous malformation.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peridiaphragmatic pathology can be imaged advantageously using multislice CT reformatted images with near isotropic resolution in the sagittal and coronal planes. The images are free of respiratory motion and devoid of the step-like artifacts that can be seen in conventional CT [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/3\" class=\"abstract_t\">3</a>].</p><p/><p>Rapid and sequential cine viewing of multiple helical CT sections, also called stack mode, enhances the radiologist's ability to detect peripheral nodules smaller than 3 mm in diameter [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/4\" class=\"abstract_t\">4</a>]. Cine viewing activates the motion processing channel in the human visual system, specifically the posterior parietal cortex [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/5\" class=\"abstract_t\">5</a>], and helps the radiologist differentiate tubular structures, such as blood vessels, from spherical structures, such as tumors. Sliding thick-slab maximum intensity projection (MIP) reformatting (eg, 8 <span class=\"nowrap\">mm/2</span> mm) is another rendering technique that facilitates differentiation of small pulmonary nodules from vascular structures imaged in cross-section. The cine display also helps the viewer assimilate information from a large number of images generated in a helical CT mode, leading to a considerable savings in time when compared with interpretation of hard copy, film display, also called shingles mode [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/4\" class=\"abstract_t\">4</a>]. In recent years, most CT interpretations have been performed on work stations rather than with films and the &quot;stack mode&quot; has become the predominant viewing mode.</p><p>Additional technical issues related to CT scanning (eg, radiation dose) are reviewed separately. (See <a href=\"topic.htm?path=principles-of-computed-tomography-of-the-chest\" class=\"medical medical_review\">&quot;Principles of computed tomography of the chest&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Solitary pulmonary nodules</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>By definition, solitary pulmonary nodules are single, rounded opacities on conventional chest radiographs that are completely surrounded by aerated lung parenchyma and measure up to 3 cm in diameter. Rounded opacities that are more than 3 cm in diameter are defined as pulmonary masses. Solitary pulmonary nodules can be further characterized by CT scans according to size, attenuation (eg, calcification, fat, liquid, soft tissues) border or margin, morphology (homogeneous or heterogeneous), enhancement pattern after injection of intravenous contrast material and growth rate [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/6-8\" class=\"abstract_t\">6-8</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Size</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Lesions larger than 3 cm (masses) are particularly likely to be malignant. In one study, 80 percent of solitary masses were found to be malignant, compared to 20 percent of nodules less than 2 cm in diameter [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/9\" class=\"abstract_t\">9</a>]. Other studies using CT have demonstrated that more than 90 percent of lesions larger than 3 cm are malignant [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/10,11\" class=\"abstract_t\">10,11</a>].</p><p>The dimensions of pulmonary nodules smaller than 10 mm should be expressed as the average of maximal long-axis and perpendicular maximal short axis measurement in the same plane. For larger nodules, both long-and short-axis measurements should be recorded. Measurements should be expressed to the nearest whole millimeter [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/12\" class=\"abstract_t\">12</a>]. Measurements are performed with electronic calipers. Special software exists for volumetric assessment of pulmonary nodules [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/13\" class=\"abstract_t\">13</a>].</p><p>A lesion of any size that is detected on imaging studies must be considered malignant until proved otherwise. However, lung cancer screening trials have clearly demonstrated a relationship between nodule diameter and the likelihood of malignancy [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/12\" class=\"abstract_t\">12</a>]. This is illustrated by the results of one such trial [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/12,14\" class=\"abstract_t\">12,14</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nodules &le;3 mm had a 0.2 percent likelihood of malignancy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nodules 4 to 7 mm had a 0.9 percent likelihood of malignancy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nodules 8 to 20 mm had a 18 percent likelihood of malignancy</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nodules &gt;20 mm had a 50 percent likelihood of malignancy</p><p/><p>Taken together, fewer than 1 percent of nodules smaller than 5 mm turned out to be malignant in patients without a history of cancer [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/12,14\" class=\"abstract_t\">12,14</a>]. Lesions exceeding 3 cm in diameter have a 90 percent likelihood of malignancy. Such estimates are difficult because up to 40 percent of diagnosed lung cancers have a diameter less than 2 cm.</p><p>The recommended frequency of follow-up, according to the size of a nodule, is reviewed separately. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-the-incidental-pulmonary-nodule#H513816847\" class=\"medical medical_review\">&quot;Diagnostic evaluation of the incidental pulmonary nodule&quot;, section on 'CT surveillance'</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Calcification</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Certain patterns of calcification of a solitary nodule are strongly suggestive of a benign lesion (<a href=\"image.htm?imageKey=PULM%2F74580\" class=\"graphic graphic_figure graphicRef74580 \">figure 1</a>) including:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diffuse, homogeneous calcification (<a href=\"image.htm?imageKey=PULM%2F75030\" class=\"graphic graphic_diagnosticimage graphicRef75030 \">image 1</a> and <a href=\"image.htm?imageKey=PULM%2F116740\" class=\"graphic graphic_diagnosticimage graphicRef116740 \">image 2</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Central calcification (<a href=\"image.htm?imageKey=PULM%2F75964\" class=\"graphic graphic_diagnosticimage graphicRef75964 \">image 3</a> and <a href=\"image.htm?imageKey=PULM%2F69188\" class=\"graphic graphic_diagnosticimage graphicRef69188 \">image 4</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lamellated (concentric) calcification (<a href=\"image.htm?imageKey=PULM%2F80141\" class=\"graphic graphic_diagnosticimage graphicRef80141 \">image 5</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>&quot;Popcorn&quot; calcification (<a href=\"image.htm?imageKey=PULM%2F80219\" class=\"graphic graphic_diagnosticimage graphicRef80219 \">image 6</a> and <a href=\"image.htm?imageKey=PULM%2F116741\" class=\"graphic graphic_diagnosticimage graphicRef116741 \">image 7</a>)</p><p/><p>Other patterns of calcification should not be considered suggestive of a benign lesion (<a href=\"image.htm?imageKey=PULM%2F79216\" class=\"graphic graphic_figure graphicRef79216 \">figure 2</a>). As an example, reticular, punctate, amorphous, or eccentric calcifications are seen in up to 6 percent of malignant nodules (<a href=\"image.htm?imageKey=PULM%2F64021\" class=\"graphic graphic_diagnosticimage graphicRef64021 \">image 8</a> and <a href=\"image.htm?imageKey=PULM%2F74827\" class=\"graphic graphic_diagnosticimage graphicRef74827 \">image 9</a>).</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Attenuation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The attenuation coefficient of a pulmonary nodule is a measure of its electron density or physical density in relation to the attenuation of water, expressed in Hounsfield units (HU) (<a href=\"image.htm?imageKey=PULM%2F82257\" class=\"graphic graphic_table graphicRef82257 \">table 1</a>). The physical density in mg per milliliters is represented by the sum of 1000 plus the attenuation in HU. The actual mass of a nodule can be computed by multiplying the volume of the nodule with the physical density, eg, mass = volume (cubic millimeters) x density <span class=\"nowrap\">(mg/mL)</span> [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/15\" class=\"abstract_t\">15</a>]. At the extremes, air has the lowest attenuation, followed by fat, while calcium and bone have high attenuation. Fat within a nodule is suggestive of a hamartoma. Calcium can be present primarily in benign nodules, although rare malignant nodules can display calcifications as well. (See <a href=\"#H6\" class=\"local\">'Calcification'</a> above.)</p><p>Noncalcified nodules are classified as ground-glass, partially solid (ie, semi-solid or mixed), or solid nodules. Ground-glass and partially solid nodules are lumped together as subsolid nodules [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/16\" class=\"abstract_t\">16</a>]. The previously used threshold of 164 HU to differentiate benign from malignant nodules has not proved useful, primarily due to difference in calibration of scanners in different institutions. Minus 291 HU has been used as a threshold for ground-glass nodules with nodules above that threshold being solid and nodules with lower attenuation than -291 being ground-glass nodules [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/15\" class=\"abstract_t\">15</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nodules composed predominantly of ground glass opacification can be seen in atypical alveolar hyperplasia (usually with a diameter of &le;5 mm) or adenocarcinoma in situ, previously called bronchioloalveolar carcinoma (usually with a diameter of &gt;5 mm). </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Partially solid nodules can be seen in minimally invasive adenocarcinoma, previously called mixed subtype adenocarcinoma. In cases where the solid nodule component exceeds 5 mm in diameter, the suspicion for a malignant process grows [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/17\" class=\"abstract_t\">17</a>]. Partially solid adenocarcinomas with a solid volume component exceeding 1.5 cubic centimeters or 63 percent of the entire nodule had an increased likelihood of recurrence or death in patients with stage I lung adenocarcinoma [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/15,18\" class=\"abstract_t\">15,18</a>]. Computer-assisted 3D CT measurements of nodules, proven to be adenocarcinomas have good correlation with pathologic findings [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/19\" class=\"abstract_t\">19</a>].</p><p/><p>This radiographic characterization strongly correlates with a pathological classification system known as Noguchi Classification: Ground-glass lesions that are &le;5 mm in diameter usually represent atypical alveolar hyperplasia, ground-glass lesions that are between 5 and 10 mm in diameter are suspicious for bronchioloalveolar carcinoma, ie, adenocarcinoma in situ, and partially solid lesions may represent the mixed subtype of adenocarcinoma, also called minimally invasive adenocarcinoma (<a href=\"image.htm?imageKey=PULM%2F83407\" class=\"graphic graphic_picture graphicRef83407 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/20,21\" class=\"abstract_t\">20,21</a>].</p><p>Solid nodules are found with invasive adenocarcinomas including lepidic, predominant, acinar, papillary, micropapillary, invasive mucinous adenocarcinomas [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/21\" class=\"abstract_t\">21</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h3\">Border</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A smooth border or margin has a 20 percent likelihood of representing a malignant nodule (<a href=\"image.htm?imageKey=PULM%2F61692\" class=\"graphic graphic_diagnosticimage graphicRef61692 \">image 10</a> and <a href=\"image.htm?imageKey=PULM%2F116739\" class=\"graphic graphic_diagnosticimage graphicRef116739 \">image 11</a>). The likelihood of malignancy increases to 60 percent with a scalloped border (<a href=\"image.htm?imageKey=PULM%2F78150\" class=\"graphic graphic_diagnosticimage graphicRef78150 \">image 12</a>), 90 percent with spiculations (<a href=\"image.htm?imageKey=PULM%2F69840\" class=\"graphic graphic_diagnosticimage graphicRef69840 \">image 13</a> and <a href=\"image.htm?imageKey=PULM%2F63489\" class=\"graphic graphic_diagnosticimage graphicRef63489 \">image 14</a> and <a href=\"image.htm?imageKey=PULM%2F51731\" class=\"graphic graphic_diagnosticimage graphicRef51731 \">image 15</a>), and 95 percent in the presence of a corona radiata (<a href=\"image.htm?imageKey=PULM%2F62360\" class=\"graphic graphic_figure graphicRef62360 \">figure 3</a>) [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/22\" class=\"abstract_t\">22</a>]. </p><p>A corona radiata describes fine linear striations that extend perpendicular to the surface of the nodule into the surrounding lung for a distance of 4 to 5 mm, like the spokes of a wheel (<a href=\"image.htm?imageKey=PULM%2F59449\" class=\"graphic graphic_diagnosticimage graphicRef59449 \">image 16</a> and <a href=\"image.htm?imageKey=PULM%2F116743\" class=\"graphic graphic_diagnosticimage graphicRef116743 \">image 17</a>).</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h3\">Morphology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Additional characteristics of the nodule's shape may be helpful [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/23-25\" class=\"abstract_t\">23-25</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nodular lesions with tails toward the hilum include rounded atelectasis, arteriovenous malformations, and, occasionally, intrapulmonary bronchogenic cysts (<a href=\"image.htm?imageKey=PULM%2F54773%7EPULM%2F66530%7EPULM%2F81990\" class=\"graphic graphic_diagnosticimage graphicRef54773 graphicRef66530 graphicRef81990 \">image 18A-C</a> and <a href=\"image.htm?imageKey=PULM%2F78745\" class=\"graphic graphic_diagnosticimage graphicRef78745 \">image 19</a>). </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peripheral carcinomas may have pleural tags extending to the periphery, away from the hilum.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lesions that are connected to blood vessels include nodular pulmonary infarcts, occasional solitary metastatic lesions, bronchopulmonary sequestrations, and arteriovenous malformations (<a href=\"image.htm?imageKey=PULM%2F56072\" class=\"graphic graphic_diagnosticimage graphicRef56072 \">image 20</a>) [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/26\" class=\"abstract_t\">26</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Multiple peripheral wedge-shaped or rounded lesions with cavitation suggest septic embolization, aspiration, or vasculitis (<a href=\"image.htm?imageKey=PULM%2F70040\" class=\"graphic graphic_diagnosticimage graphicRef70040 \">image 21</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nodules that are smooth, attached to the pleura, attached to fissures or perifissural in location [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/27,28\" class=\"abstract_t\">27,28</a>], in close apposition to vessels, and smaller than 10 mm in diameter are likely benign [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/29\" class=\"abstract_t\">29</a>]. Such lesions are usually intrapulmonary lymph nodes, nodular scars, granulomata, nodular pleural plaques, or impacted bronchi. Intrapulmonary lymph nodes are regularly found abutting interlobar fissures with an elliptical or triangular shape and a diameter that only rarely exceeds 5 mm.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cavitated nodules with a thin wall are more likely to be benign than cavitated nodules with a thick wall. In one study, cavitated nodules with a thin wall (&le;4 mm) were benign in 95 percent of cases [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/30\" class=\"abstract_t\">30</a>]. Cavitated nodules with a wall thickness of 5 to 15 mm were benign in 73 percent of cases, while cavitated nodules with a wall thickness &ge;16 mm were benign in only 16 percent of cases. Among the benign cavitary lesions, abscesses, necrobiotic nodules in rheumatoid arthritis and infected emphysematous bullae have to be considered (<a href=\"image.htm?imageKey=PULM%2F56201\" class=\"graphic graphic_diagnosticimage graphicRef56201 \">image 22</a> and <a href=\"image.htm?imageKey=PULM%2F77861\" class=\"graphic graphic_picture graphicRef77861 \">picture 2</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Thin-walled cysts or pneumatoceles may be seen with coccidioidomycosis, pneumocystis pneumonia, staphylococcal pneumonia, with chemical pneumonia after accidental hydrocarbon ingestion [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/31\" class=\"abstract_t\">31</a>], after barotrauma due to mechanical ventilation, and with metastases from transitional carcinoma of the bladder (<a href=\"image.htm?imageKey=PULM%2F53339\" class=\"graphic graphic_diagnosticimage graphicRef53339 \">image 23</a>). They may also be seen following traumatic pulmonary laceration.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A halo may be seen surrounding a nodule in the setting of angioinvasive aspergillosis, zygomycosis (mucormycosis), Fusarium or Scedosporium infections, lymphoma, adenocarcinoma in situ, coccidioidomycosis, or (rarely) bacterial infections.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nodules surrounded by small satellite lesions are benign 90 percent of the time.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Crescent signs (ie, a thin, curvilinear lucent line) are seen in cavitating necrotic lung lesions forming a necrotic lung ball (<a href=\"image.htm?imageKey=PULM%2F77137\" class=\"graphic graphic_diagnosticimage graphicRef77137 \">image 24</a>). They can be simulated by small fungus balls (mycetomas) within preexisting cavities (ie, Monod sign). These entities can be distinguished by imaging the patient in different positions: necrotic lung balls are fixed to the wall of the cavities and do not move with positional maneuvers, whereas true fungus balls (mycetomas) change their position on decubitus views, for instance, since they are mobile (<a href=\"image.htm?imageKey=PULM%2F64248%7EPULM%2F77086\" class=\"graphic graphic_diagnosticimage graphicRef64248 graphicRef77086 \">image 25A-B</a>).</p><p/><p>CT radiogenomic characterization is being attempted: molecular phenotype in non-small cell lung cancer has shown correlation between the location of tumors and anaplastic lymphoma kinase (ALK)-positive status. Such tumors display on CT scans a central location, absence of pleural tags or tails, and an association with large pleural effusions [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/32\" class=\"abstract_t\">32</a>].</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Growth</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Review of available prior chest radiographs is a critical part of the diagnostic evaluation [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/12\" class=\"abstract_t\">12</a>]. Lesions that are malignant tend to have a doubling time (the time necessary for the lesion to double its volume) between 30 and 480 days (ie, between 1 and 16 months), while benign lesions generally have a doubling time that is either less than 30 days (some infectious causes) or greater than 480 days (chronic granulomatous lesions) [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/33\" class=\"abstract_t\">33</a>]. Exceptions to this rule can be found with occasional adenocarcinomas in situ or minimally invasive adenocarcinomas, which exhibit a doubling time of up to 900 days [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/34\" class=\"abstract_t\">34</a>].</p><p>The fastest growing lung cancer, small cell carcinoma, has a median doubling time of about 30 days. Invasive adenocarcinoma has a median doubling time of 180 days, while squamous cell carcinomas have a doubling time of 90 to 140 days.</p><p>Using the growth rate to distinguish benign from malignant lesions has pitfalls:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Small differences in diameter can have a profound effect on the nodule volume. This is illustrated by the formula for the volume of a sphere, [4&pi;]r<sup>3</sup> &divide; 3, where r represents the radius of the nodule. A nodule that has a diameter of 1 cm would have doubled in volume if its diameter increased by as little as 2.5 mm. Nodules with diameters of 2 and 3 cm would have doubled in volume if their diameters increased 5 and 8 mm, respectively. Thus, the growth of smaller nodules is more difficult to substantiate and document. Volumetric three-dimensional rendering and advanced post-processing software can detect early changes in configuration and subtle growth in the longitudinal or z-axis that may elude conventional two dimensional measurements [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/35-37\" class=\"abstract_t\">35-37</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Exceptions to the range of doubling times for malignant lesions mentioned above exist. Low grade malignant lesions (eg, bronchial carcinoid with typical histology) may have a doubling time that exceeds 480 days, while adenocarcinoma in situ (bronchioloalveolar carcinoma), may have a radiographic doubling time beyond 800 days. In contrast, Epstein-Barr virus (EBV)-associated lymphoma or lung cancer may exhibit very fast doubling times in HIV positive patients. Inflammatory lesions have a short doubling time as well [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/28\" class=\"abstract_t\">28</a>]. </p><p/><p>As a general guideline, two years of radiographic stability strongly suggest that a lesion is benign [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/38,39\" class=\"abstract_t\">38,39</a>]. When following up ground-glass or sub-solid nodules, three to four years of size stability are recommended with an initial early three month follow-up in order to detect clearing of potentially benign, inflammatory processes, which would obviate long-term surveillance [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/40\" class=\"abstract_t\">40</a>].</p><p class=\"headingAnchor\" id=\"H2985669\"><span class=\"h2\">Multiple nodules</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Multiple pulmonary nodules detected by CT scanning frequently turn out to represent metastatic disease. Such lesions are in the 5 mm range or smaller, subpleural, hidden by cardiomediastinal structures and the domes of the diaphragm, and easily missed by chest radiographs [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/41,42\" class=\"abstract_t\">41,42</a>].</p><p>Most patients with pulmonary metastases will display multiple nodules on CT (ie, CT has high sensitivity); however, a plurality of patients without metastatic disease will also show multiple pulmonary lesions (ie, CT has low specificity). The specificity is higher in children than in adult patients, owing to the fact that adults have had more exposure to infectious and granulomatous agents during their life.</p><p>Nonmalignant causes of multiple pulmonary nodules include granulomatous infections, intrapulmonary lymph nodes, septic emboli, sarcoidosis, granulomatosis with polyangiitis (formerly called Wegener's granulomatosis), amyloidosis, and rheumatoid arthritis-associated pulmonary disease. (See <a href=\"topic.htm?path=differential-diagnosis-and-evaluation-of-multiple-pulmonary-nodules\" class=\"medical medical_review\">&quot;Differential diagnosis and evaluation of multiple pulmonary nodules&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">POSITRON EMISSION TOMOGRAPHY (PET)</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>PET allows functional imaging of structures by virtue of their ability to metabolize glucose and concentrate specific molecules that have been labeled with a positron-emitting radionuclide [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/43\" class=\"abstract_t\">43</a>]. It is usually performed in a patient with a known or suspected malignancy using a glucose analog that has been tagged with a positron-emitting isotope of fluorine, (18)F-2-deoxy-2-fluoro-D-glucose (FDG). Metabolically active cells (eg, malignant cells) utilize and import more glucose than other tissues and, thus, take up FDG more avidly (<a href=\"image.htm?imageKey=PULM%2F79380\" class=\"graphic graphic_diagnosticimage graphicRef79380 \">image 26</a>) [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/44\" class=\"abstract_t\">44</a>]. Technical aspects of PET are discussed elsewhere. (See <a href=\"topic.htm?path=thoracic-positron-emission-tomography\" class=\"medical medical_review\">&quot;Thoracic positron emission tomography&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Test characteristics</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>FDG-PET is more accurate than computed tomography (CT) in differentiating benign from malignant lesions as small as 0.7 to 1 cm in diameter [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/45\" class=\"abstract_t\">45</a>]. It is estimated that 96 percent of patients with lung cancer will have an abnormal FDG-PET (ie, sensitivity) and 79 percent of patients without lung cancer will have a normal FDG-PET (ie, specificity), a diagnostic accuracy of 91 percent [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/45-47\" class=\"abstract_t\">45-47</a>].</p><p>FDG-PET correctly excludes cancer in most cases (ie, good negative predictive value) [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/45,48\" class=\"abstract_t\">45,48</a>]. However, it is not uncommon for an FDG-PET positive nodule to be infectious, inflammatory, or granulomatous in origin (ie, moderate positive predictive value) [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/45\" class=\"abstract_t\">45</a>].</p><p>False-negative results can occur with tumors that have low metabolic activity (eg, adenocarcinoma in situ, carcinoids, and some well-differentiated adenocarcinomas), small lesions (a critical mass of metabolically active malignant cells is required for detection by PET), and uncontrolled hyperglycemia, which leads to glucose saturation and subsequent delayed uptake of FDG since glucose competes with deoxy-2-fluoro-D glucose for the transmembrane transport into the cell [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/43,45\" class=\"abstract_t\">43,45</a>]. False-positive results can occur in inflammatory conditions and granulomatous diseases [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/45\" class=\"abstract_t\">45</a>]. (See <a href=\"topic.htm?path=thoracic-positron-emission-tomography#H5\" class=\"medical medical_review\">&quot;Thoracic positron emission tomography&quot;, section on 'Sources of error'</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Metabolic activity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A tumor's metabolic activity can be measured using the standardized uptake value (SUV, formerly called standard uptake ratio). A high SUV indicates robust FDG uptake due to high metabolic glycolytic activity, which suggests malignancy (or active inflammation).</p><p>The SUV can be interpreted visually in a qualitative fashion or quantitatively, with comparable accuracy [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/49\" class=\"abstract_t\">49</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Qualitative assessment &ndash; FDG uptake by the tumor is compared to background activity by visual inspection.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Quantitative assessment &ndash; a numerical value is determined from the PET scan. An SUV exceeding 2.5 is generally considered highly suggestive of malignancy or active inflammation. Each institution must establish its own cutoff value because the SUV depends upon multiple parameters, including the activity of the FDG, the timing between injection and scanning, and the size and location of the lesion.</p><p/><p>The SUV may provide additional prognostic information in patients with lung cancer and help in the assessment of the response to treatment, as well as in the detection of tumor recurrence [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/34,50,51\" class=\"abstract_t\">34,50,51</a>]. This is discussed separately. (See <a href=\"topic.htm?path=overview-of-the-initial-evaluation-treatment-and-prognosis-of-lung-cancer#H13\" class=\"medical medical_review\">&quot;Overview of the initial evaluation, treatment and prognosis of lung cancer&quot;, section on 'Prognosis'</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">PET/CT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Integrated computed tomography and positron emission tomography <span class=\"nowrap\">(PET/CT)</span> appears to more accurately characterize solitary pulmonary nodules (SPNs) as benign or malignant than either modality alone [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/52,53\" class=\"abstract_t\">52,53</a>]. This was illustrated by an observational study of 42 patients with an SPN [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/53\" class=\"abstract_t\">53</a>]. CT, PET, and <span class=\"nowrap\">CT/PET</span> correctly characterized 74, 74, and 93 percent of SPNs, respectively, as benign or malignant. Other experts, including those at UpToDate disagree on the value of <span class=\"nowrap\">PET/CT</span> for the assessment of SPNs. At some institutions <span class=\"nowrap\">PET/CT</span> is often the only modality available for functional assessment of SPNs. If only a PET scan is available, a side by side comparison of a contemporaneous CT scan with the FDG PET scan will allow for subjective, visual fusion of those two imaging modalities and yield comparable results. Thus, the optimal practice should be individualized at each institution. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-the-incidental-pulmonary-nodule#H1486138141\" class=\"medical medical_review\">&quot;Diagnostic evaluation of the incidental pulmonary nodule&quot;, section on 'Positron emission tomography/computed tomography'</a>.)</p><p><span class=\"nowrap\">PET/CT</span> can characterize SPNs in patients who have a history of cancer. In one observational study that included 56 such patients, malignant SPNs were diagnosed by visual criteria with a sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 96, 83, 84, 96, and 89 percent, respectively [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/54\" class=\"abstract_t\">54</a>]. Malignant SPNs were diagnosed by semiquantitative criteria with a sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of 89, 93, 92, 90, and 91 percent, respectively.</p><p>False negative <span class=\"nowrap\">PET/CT</span> scans have occurred in patients with adenocarcinoma in situ (bronchioloalveolar carcinoma), carcinoid tumors, tuberculosis, and renal cell carcinoma [<a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/54\" class=\"abstract_t\">54</a>]. False positive CT-PET have occurred in patients with fungal infection. </p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=multiple-pulmonary-nodules-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Multiple pulmonary nodules (The Basics)&quot;</a> and <a href=\"topic.htm?path=pulmonary-nodule-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Pulmonary nodule (The Basics)&quot;</a>)</p><p/><p/><p class=\"headingAnchor\" id=\"H2984967\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary nodules are rounded opacities that are completely surrounded by aerated lung parenchyma and measure up to 3 cm in diameter. They can be solitary or multiple. In contrast, rounded opacities that are more than 3 cm in diameter are labeled as pulmonary masses. (See <a href=\"#H4\" class=\"local\">'Solitary pulmonary nodules'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Computed tomography (CT) is an important tool in the evaluation of pulmonary nodules. It characterizes nodules on the basis of size, attenuation, including calcification, border, morphology, and growth rate. CT detects additional nodules that elude chest radiography and delineates other intrathoracic abnormalities, such as enlarged mediastinal lymph nodes. (See <a href=\"#H5\" class=\"local\">'Size'</a> above and <a href=\"#H6\" class=\"local\">'Calcification'</a> above and <a href=\"#H7\" class=\"local\">'Attenuation'</a> above and <a href=\"#H8\" class=\"local\">'Border'</a> above and <a href=\"#H9\" class=\"local\">'Morphology'</a> above and <a href=\"#H10\" class=\"local\">'Growth'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Positron emission tomography (PET) is a nuclear imaging technique that provides insight into the metabolic activity of a pulmonary lesion and, by inference, yields information about the probability of malignancy. It is more accurate than CT in differentiating benign from malignant lesions as small as 0.7 to 1 cm in diameter. PET correctly excludes cancer in most cases (ie, it has good negative predictive value), but it is possible for a nodule with a positive PET to be infectious, inflammatory, or granulomatous in nature (ie, it has moderate positive predictive value). (See <a href=\"#H11\" class=\"local\">'Positron emission tomography (PET)'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Integrated positron emission tomography and CT scanning <span class=\"nowrap\">(PET/CT)</span> appears to more accurately characterize pulmonary lesions as benign or malignant than either modality alone. (See <a href=\"#H14\" class=\"local\">'PET/CT'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/1\" class=\"nounderline abstract_t\">Costello P, Anderson W, Blume D. Pulmonary nodule: evaluation with spiral volumetric CT. Radiology 1991; 179:875.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/2\" class=\"nounderline abstract_t\">Remy-Jardin M, Remy J, Giraud F, Marquette CH. Pulmonary nodules: detection with thick-section spiral CT versus conventional CT. Radiology 1993; 187:513.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/3\" class=\"nounderline abstract_t\">Costello P. Spiral CT of the thorax. Semin Ultrasound CT MR 1994; 15:90.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/4\" class=\"nounderline abstract_t\">Seltzer SE, Judy PF, Adams DF, et al. Spiral CT of the chest: comparison of cine and film-based viewing. Radiology 1995; 197:73.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/5\" class=\"nounderline abstract_t\">Buckle CE, Udawatta V, Straus CM. Now you see it, now you don't: visual illusions in radiology. Radiographics 2013; 33:2087.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/6\" class=\"nounderline abstract_t\">Winer-Muram HT. The solitary pulmonary nodule. Radiology 2006; 239:34.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/7\" class=\"nounderline abstract_t\">Erasmus JJ, Connolly JE, McAdams HP, Roggli VL. Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions. Radiographics 2000; 20:43.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/8\" class=\"nounderline abstract_t\">Erasmus JJ, McAdams HP, Connolly JE. Solitary pulmonary nodules: Part II. Evaluation of the indeterminate nodule. Radiographics 2000; 20:59.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/9\" class=\"nounderline abstract_t\">STEELE JD. THE SOLITARY PULMONARY NODULE. REPORT OF A COOPERATIVE STUDY OF RESECTED ASYMPTOMATIC SOLITARY PULMONARY NODULES IN MALES. J Thorac Cardiovasc Surg 1963; 46:21.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/10\" class=\"nounderline abstract_t\">Zerhouni EA, Stitik FP, Siegelman SS, et al. CT of the pulmonary nodule: a cooperative study. Radiology 1986; 160:319.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/11\" class=\"nounderline abstract_t\">Siegelman SS, Khouri NF, Leo FP, et al. Solitary pulmonary nodules: CT assessment. Radiology 1986; 160:307.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/12\" class=\"nounderline abstract_t\">Bankier AA, MacMahon H, Goo JM, et al. Recommendations for Measuring Pulmonary Nodules at CT: A Statement from the Fleischner Society. Radiology 2017; 285:584.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/13\" class=\"nounderline abstract_t\">Devaraj A, van Ginneken B, Nair A, Baldwin D. Use of Volumetry for Lung Nodule Management: Theory and Practice. Radiology 2017; 284:630.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/14\" class=\"nounderline abstract_t\">Midthun DE, Swensen SJ, Jett JR. Evaluation of  nodules detected by screening for lung cancer with low dose spiral computed tomography. Lung Cancer 2003; 41:S40.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/15\" class=\"nounderline abstract_t\">Yanagawa M, Tanaka Y, Leung AN, et al. Prognostic importance of volumetric measurements in stage I lung adenocarcinoma. Radiology 2014; 272:557.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/16\" class=\"nounderline abstract_t\">Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013; 266:304.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/17\" class=\"nounderline abstract_t\">Lee SM, Park CM, Goo JM, et al. Invasive pulmonary adenocarcinomas versus preinvasive lesions appearing as ground-glass nodules: differentiation by using CT features. Radiology 2013; 268:265.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/18\" class=\"nounderline abstract_t\">Borczuk AC. Over- and Underdiagnosis in Lung Cancer: Searching for a &quot;Solid&quot; Diagnosis. Radiology 2016; 280:655.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/19\" class=\"nounderline abstract_t\">Ko JP, Suh J, Ibidapo O, et al. Lung Adenocarcinoma: Correlation of Quantitative CT Findings with Pathologic Findings. Radiology 2016; 280:931.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/20\" class=\"nounderline abstract_t\">Godoy MC, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology 2009; 253:606.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/21\" class=\"nounderline abstract_t\">Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6:244.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/22\" class=\"nounderline abstract_t\">Rigler LG. An overview of cancer of the lung. Semin Roentgenol 1977; 12:161.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/23\" class=\"nounderline abstract_t\">Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002; 178:1053.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/24\" class=\"nounderline abstract_t\">Winer-Muram HT, Jennings SG, Tarver RD, et al. Volumetric growth rate of stage I lung cancer prior to treatment: serial CT scanning. Radiology 2002; 223:798.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/25\" class=\"nounderline abstract_t\">Tsubamoto M, Kuriyama K, Kido S, et al. Detection of lung cancer on chest radiographs: analysis on the basis of size and extent of ground-glass opacity at thin-section CT. Radiology 2002; 224:139.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/26\" class=\"nounderline abstract_t\">Remy J, Remy-Jardin M, Wattinne L, Deffontaines C. Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 1992; 182:809.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/27\" class=\"nounderline abstract_t\">Ahn MI, Gleeson TG, Chan IH, et al. Perifissural nodules seen at CT screening for lung cancer. Radiology 2010; 254:949.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/28\" class=\"nounderline abstract_t\">de Hoop B, van Ginneken B, Gietema H, Prokop M. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy. Radiology 2012; 265:611.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/29\" class=\"nounderline abstract_t\">Xu DM, van der Zaag-Loonen HJ, Oudkerk M, et al. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Radiology 2009; 250:264.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/30\" class=\"nounderline abstract_t\">Woodring JH, Fried AM. Significance of wall thickness in solitary cavities of the lung: a follow-up study. AJR Am J Roentgenol 1983; 140:473.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/31\" class=\"nounderline abstract_t\">Harris VJ, Brown R. Pneumatoceles as a complication of chemical pneumonia after hydrocarbon ingestion. Am J Roentgenol Radium Ther Nucl Med 1975; 125:531.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/32\" class=\"nounderline abstract_t\">Yamamoto S, Korn RL, Oklu R, et al. ALK molecular phenotype in non-small cell lung cancer: CT radiogenomic characterization. Radiology 2014; 272:568.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/33\" class=\"nounderline abstract_t\">Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96:440.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/34\" class=\"nounderline abstract_t\">Nishino M, Hatabu H, Johnson BE, McLoud TC. State of the art: Response assessment in lung cancer in the era of genomic medicine. Radiology 2014; 271:6.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/35\" class=\"nounderline abstract_t\">Honda O, Johkoh T, Sumikawa H, et al. Pulmonary nodules: 3D volumetric measurement with multidetector CT--effect of intravenous contrast medium. Radiology 2007; 245:881.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/36\" class=\"nounderline abstract_t\">Kim H, Park CM, Woo S, et al. Pure and part-solid pulmonary ground-glass nodules: measurement variability of volume and mass in nodules with a solid portion less than or equal to 5 mm. Radiology 2013; 269:585.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/37\" class=\"nounderline abstract_t\">Chae HD, Park CM, Park SJ, et al. Computerized texture analysis of persistent part-solid ground-glass nodules: differentiation of preinvasive lesions from invasive pulmonary adenocarcinomas. Radiology 2014; 273:285.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/38\" class=\"nounderline abstract_t\">Williams DE, Pairolero PC, Davis CS, et al. Survival of patients surgically treated for stage I lung cancer. J Thorac Cardiovasc Surg 1981; 82:70.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/39\" class=\"nounderline abstract_t\">Midthun DE, Swensen SJ, Jett JR. Approach to the solitary pulmonary nodule. Mayo Clin Proc 1993; 68:378.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/40\" class=\"nounderline abstract_t\">Song YS, Park CM, Park SJ, et al. Volume and mass doubling times of persistent pulmonary subsolid nodules detected in patients without known malignancy. Radiology 2014; 273:276.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/41\" class=\"nounderline abstract_t\">Libshitz HI, North LB. Pulmonary metastases. Radiol Clin North Am 1982; 20:437.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/42\" class=\"nounderline abstract_t\">Chang AE, Schaner EG, Conkle DM, et al. Evaluation of computed tomography in the detection of pulmonary metastases: a prospective study. Cancer 1979; 43:913.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/43\" class=\"nounderline abstract_t\">Lowe VJ, Naunheim KS. Positron emission tomography in lung cancer. Ann Thorac Surg 1998; 65:1821.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/44\" class=\"nounderline abstract_t\">Nolop KB, Rhodes CG, Brudin LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987; 60:2682.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/45\" class=\"nounderline abstract_t\">Vansteenkiste JF, Stroobants SS. PET scan in lung cancer: current recommendations and innovation. J Thorac Oncol 2006; 1:71.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/46\" class=\"nounderline abstract_t\">Vansteenkiste JF, Stroobants SG. The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology. Eur Respir J 2001; 17:802.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/47\" class=\"nounderline abstract_t\">Fischer BM, Mortensen J, H&oslash;jgaard L. Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review. Lancet Oncol 2001; 2:659.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/48\" class=\"nounderline abstract_t\">Vansteenkiste JF. Nodules, CT-scans and PET-scans: a good partnership. Lung Cancer 2004; 45:29.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/49\" class=\"nounderline abstract_t\">Lowe VJ, Hoffman JM, DeLong DM, et al. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 1994; 35:1771.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/50\" class=\"nounderline abstract_t\">Cook GJ, O'Brien ME, Siddique M, et al. Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis. Radiology 2015; 276:883.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/51\" class=\"nounderline abstract_t\">Soussan M, Cyrta J, Pouliquen C, et al. Fluorine 18 fluorodeoxyglucose PET/CT volume-based indices in locally advanced non-small cell lung cancer: prediction of residual viable tumor after induction chemotherapy. Radiology 2014; 272:875.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/52\" class=\"nounderline abstract_t\">Yi CA, Lee KS, Kim BT, et al. Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. J Nucl Med 2006; 47:443.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/53\" class=\"nounderline abstract_t\">Kim SK, Allen-Auerbach M, Goldin J, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med 2007; 48:214.</a></li><li><a href=\"https://www.uptodate.com/contents/computed-tomographic-and-positron-emission-tomographic-scanning-of-pulmonary-nodules/abstract/54\" class=\"nounderline abstract_t\">Bar-Shalom R, Kagna O, Israel O, Guralnik L. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography. Cancer 2008; 113:3213.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6977 Version 21.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H2984967\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">COMPUTED TOMOGRAPHY (CT)</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Technical aspects</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Solitary pulmonary nodules</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">- Size</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">- Calcification</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Attenuation</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">- Border</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">- Morphology</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">- Growth</a></li></ul></li><li><a href=\"#H2985669\" id=\"outline-link-H2985669\">Multiple nodules</a></li></ul></li><li><a href=\"#H11\" id=\"outline-link-H11\">POSITRON EMISSION TOMOGRAPHY (PET)</a><ul><li><a href=\"#H12\" id=\"outline-link-H12\">Test characteristics</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Metabolic activity</a></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">PET/CT</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H27700350\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H2984967\" id=\"outline-link-H2984967\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PULM/6977|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/75030\" class=\"graphic graphic_diagnosticimage\">- Calcified granuloma CT</a></li><li><a href=\"image.htm?imageKey=PULM/116740\" class=\"graphic graphic_diagnosticimage\">- Part-solid SPN</a></li><li><a href=\"image.htm?imageKey=PULM/75964\" class=\"graphic graphic_diagnosticimage\">- Central calcification on CT</a></li><li><a href=\"image.htm?imageKey=PULM/69188\" class=\"graphic graphic_diagnosticimage\">- Central calcification on CT II</a></li><li><a href=\"image.htm?imageKey=PULM/80141\" class=\"graphic graphic_diagnosticimage\">- Solitary pulmonary granuloma</a></li><li><a href=\"image.htm?imageKey=PULM/80219\" class=\"graphic graphic_diagnosticimage\">- CT of a pulmonary hamartoma</a></li><li><a href=\"image.htm?imageKey=PULM/116741\" class=\"graphic graphic_diagnosticimage\">- Hamartoma</a></li><li><a href=\"image.htm?imageKey=PULM/64021\" class=\"graphic graphic_diagnosticimage\">- Bronchogenic carcinoma CT VII</a></li><li><a href=\"image.htm?imageKey=PULM/74827\" class=\"graphic graphic_diagnosticimage\">- Bronchogenic carcinoma CT VIII</a></li><li><a href=\"image.htm?imageKey=PULM/61692\" class=\"graphic graphic_diagnosticimage\">- Carcinoid tumor CT</a></li><li><a href=\"image.htm?imageKey=PULM/116739\" class=\"graphic graphic_diagnosticimage\">- Infectious SPN</a></li><li><a href=\"image.htm?imageKey=PULM/78150\" class=\"graphic graphic_diagnosticimage\">- Calcified pleural plaque CT I</a></li><li><a href=\"image.htm?imageKey=PULM/69840\" class=\"graphic graphic_diagnosticimage\">- Solitary pulmonary nodule CT I</a></li><li><a href=\"image.htm?imageKey=PULM/63489\" class=\"graphic graphic_diagnosticimage\">- Spiculated nodule CT</a></li><li><a href=\"image.htm?imageKey=PULM/51731\" class=\"graphic graphic_diagnosticimage\">- Spiculated carcinoma CT</a></li><li><a href=\"image.htm?imageKey=PULM/59449\" class=\"graphic graphic_diagnosticimage\">- Spiculated pulmonary nodule</a></li><li><a href=\"image.htm?imageKey=PULM/116743\" class=\"graphic graphic_diagnosticimage\">- Cavitating SPN</a></li><li><a href=\"image.htm?imageKey=PULM/54773\" class=\"graphic graphic_diagnosticimage\">- Arteriovenous malformation I</a></li><li><a href=\"image.htm?imageKey=PULM/66530\" class=\"graphic graphic_diagnosticimage\">- Arteriovenous malformation II</a></li><li><a href=\"image.htm?imageKey=PULM/81990\" class=\"graphic graphic_diagnosticimage\">- Arteriovenous malformation III</a></li><li><a href=\"image.htm?imageKey=PULM/78745\" class=\"graphic graphic_diagnosticimage\">- Rounded atelectasis CT</a></li><li><a href=\"image.htm?imageKey=PULM/56072\" class=\"graphic graphic_diagnosticimage\">- CT of a pulmonary arteriovenous malformation</a></li><li><a href=\"image.htm?imageKey=PULM/70040\" class=\"graphic graphic_diagnosticimage\">- Septic emboli</a></li><li><a href=\"image.htm?imageKey=PULM/56201\" class=\"graphic graphic_diagnosticimage\">- Abscess cavity</a></li><li><a href=\"image.htm?imageKey=PULM/53339\" class=\"graphic graphic_diagnosticimage\">- Post traumatic lung cyst CT</a></li><li><a href=\"image.htm?imageKey=PULM/77137\" class=\"graphic graphic_diagnosticimage\">- Lung gangrene</a></li><li><a href=\"image.htm?imageKey=PULM/64248\" class=\"graphic graphic_diagnosticimage\">- Saprophytic aspergillus CT I</a></li><li><a href=\"image.htm?imageKey=PULM/77086\" class=\"graphic graphic_diagnosticimage\">- Saprophytic aspergillus CT II</a></li><li><a href=\"image.htm?imageKey=PULM/79380\" class=\"graphic graphic_diagnosticimage\">- Solitary pulmonary nodule FDG</a></li></ul></li><li><div id=\"PULM/6977|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/74580\" class=\"graphic graphic_figure\">- Pattern of benign calcification</a></li><li><a href=\"image.htm?imageKey=PULM/79216\" class=\"graphic graphic_figure\">- Malignant calcification pattern</a></li><li><a href=\"image.htm?imageKey=PULM/62360\" class=\"graphic graphic_figure\">- Margin of pulmonary nodules</a></li></ul></li><li><div id=\"PULM/6977|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/83407\" class=\"graphic graphic_picture\">- Ground glass nodule</a></li><li><a href=\"image.htm?imageKey=PULM/77861\" class=\"graphic graphic_picture\">- Infected bulla</a></li></ul></li><li><div id=\"PULM/6977|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/82257\" class=\"graphic graphic_table\">- Attenuation coefficient nodule</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-evaluation-of-the-incidental-pulmonary-nodule\" class=\"medical medical_review\">Diagnostic evaluation of the incidental pulmonary nodule</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=differential-diagnosis-and-evaluation-of-multiple-pulmonary-nodules\" class=\"medical medical_review\">Differential diagnosis and evaluation of multiple pulmonary nodules</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=high-resolution-computed-tomography-of-the-lungs\" class=\"medical medical_review\">High resolution computed tomography of the lungs</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-initial-evaluation-treatment-and-prognosis-of-lung-cancer\" class=\"medical medical_review\">Overview of the initial evaluation, treatment and prognosis of lung cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=multiple-pulmonary-nodules-the-basics\" class=\"medical medical_basics\">Patient education: Multiple pulmonary nodules (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pulmonary-nodule-the-basics\" class=\"medical medical_basics\">Patient education: Pulmonary nodule (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=principles-of-computed-tomography-of-the-chest\" class=\"medical medical_review\">Principles of computed tomography of the chest</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=thoracic-positron-emission-tomography\" class=\"medical medical_review\">Thoracic positron emission tomography</a></li></ul></div></div>","javascript":null}